Education
About Us
Working with TipRanks
Follow Us
Towa Pharmaceutical Co Ltd (TWAPF)
OTHER OTC:TWAPF
TWAPF Stock Chart & Stats
$25.33
$0.00(0.00%)
At close: 4:00 PM EST
$25.33
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$15.12 - $25.33
Previous CloseN/A
Volume1.00
Average Volume (3M)0.00
Market Cap
$979.16M
Enterprise Value$332.01B
Total Cash (Recent Filing)$52.94B
Total Debt (Recent Filing)$237.89B
Price to Earnings (P/E)9.1
Beta0.39
Next Earnings
Feb 16, 2026EPS EstimateN/A
Next Dividend Ex-Date
Mar 31, 2026Dividend Yield3.18%
Share Statistics
EPS (TTM)0.74
Shares Outstanding51,516,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.40
Price to Book (P/B)0.77
Price to Sales (P/S)0.51
P/FCF Ratio-24.72
Enterprise Value/Market Cap339.07
Enterprise Value/Revenue1.27
Enterprise Value/Gross Profit3.49
Enterprise Value/Ebitda6.27
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Towa Pharmaceutical Co News
TWAPF FAQ
What was Towa Pharmaceutical Co Ltd’s price range in the past 12 months?
Towa Pharmaceutical Co Ltd lowest stock price was $15.12 and its highest was $25.33 in the past 12 months.
What is Towa Pharmaceutical Co Ltd’s market cap?
Towa Pharmaceutical Co Ltd’s market cap is $979.16M.
When is Towa Pharmaceutical Co Ltd’s upcoming earnings report date?
Towa Pharmaceutical Co Ltd’s upcoming earnings report date is Feb 16, 2026 which is in 70 days.
How were Towa Pharmaceutical Co Ltd’s earnings last quarter?
Towa Pharmaceutical Co Ltd released its earnings results on Nov 10, 2025. The company reported $0.735 earnings per share for the quarter, beating the consensus estimate of $0.394 by $0.342.
Is Towa Pharmaceutical Co Ltd overvalued?
According to Wall Street analysts Towa Pharmaceutical Co Ltd’s price is currently Overvalued.
Does Towa Pharmaceutical Co Ltd pay dividends?
Towa Pharmaceutical Co Ltd pays a Semiannually dividend of $0.258 which represents an annual dividend yield of 3.18%. See more information on Towa Pharmaceutical Co Ltd dividends here
What is Towa Pharmaceutical Co Ltd’s EPS estimate?
Towa Pharmaceutical Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Towa Pharmaceutical Co Ltd have?
Towa Pharmaceutical Co Ltd has 51,516,000 shares outstanding.
What happened to Towa Pharmaceutical Co Ltd’s price movement after its last earnings report?
Towa Pharmaceutical Co Ltd reported an EPS of $0.735 in its last earnings report, beating expectations of $0.394. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Towa Pharmaceutical Co Ltd?
Currently, no hedge funds are holding shares in TWAPF
Company Description
Towa Pharmaceutical Co Ltd
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.
Technical Analysis
Kaken Pharmaceutical Co
―
Kissei Pharmaceutical Co
―
Torii Pharmaceutical Co
―
KYORIN Pharmaceutical Co.,Ltd.
―
SAWAI GROUP HOLDINGS Co., Ltd.
―
Ownership Overview
―
Insiders
7.53% Mutual Funds
― Other Institutional Investors
88.84% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---